In-silico vaccine design construction of Human papillomavirus

Abstract

Human Papillomavirus (HPV) is a leading cause of oropharyngeal cancer, causes a significant health risk worldwide. Traditional vaccine development processes are often time-consuming and costly, making alternative approaches necessary. This study focuses on the use of computational methods to design a vaccine against HPV-related oropharyngeal cancer. Using in-silico techniques to find CTL, HTL and B CELL of HPV proteins, known as epitopes, were identified for their ability to stimulate the immune system. These epitopes were carefully selected based on their potential to generate a strong immune response while ensuring safety for human use. The chosen epitopes were assembled into a multi-epitope vaccine construct, enhanced with adjuvants to improve immune activation. The vaccine’s structure was modeled and optimized for stability and effectiveness. Molecular docking studies were conducted to evaluate the interaction between the vaccine and human immune receptors, demonstrating a strong potential for immune system activation. Immune simulation results suggested that the vaccine could trigger both cellular and humoral responses, offering long-term protection against HPV-induced oropharyngeal cancer. This study highlights the potential of in-silico vaccine design as a faster and more cost-effective method for developing vaccines, with promising implications for preventing HPV-related oropharyngeal cancer.